Prime Health review

This is the promise this site exists to check, and Prime Health makes it in the strongest place available — not a badge, not a marketing line, but a field in the page's own data reading that the price remains the same at all doses. For someone intending to hold low that is exactly the right structure, because the dose stops being a budgeting decision. Then read the unit. Its own FAQ quotes a monthly figure for each molecule and, in the same sentence, says that figure buys four weeks of medication. Four weeks is not a month, so the charge lands thirteen times in a year rather than twelve and the true annual cost runs roughly eight percent above what the monthly label implies. That is disclosed rather than hidden, and still easy to read straight past. The other limits are ordinary — no pharmacy is named, so you cannot check who compounds the vial before you commit, and the money-back guarantee is real but claimable only inside a 14-day window after week sixteen.

Vs median

$130/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

Prime Health dispenses through a Not named facility. No bloodwork is required before you start. A clinician review is included in the price.

Prime Health sells compounded semaglutide and compounded tirzepatide as one recurring all-inclusive charge per molecule, with unlimited clinician access and the medication inside the figure. The flat-dose claim is the strongest kind this site looks for: it is not a badge or a marketing line but a field in the page's own data — "Price remains THE SAME at all doses" — which means a patient holding at a quarter dose pays exactly what a patient at a full dose pays. For a low-dose reader that removes the usual penalty, and it removes the usual reward too. The complication is the unit. The provider's own FAQ prices the plan per month and then defines what a month contains: four weeks of medication. Four weeks is not a calendar month, so the charge recurs thirteen times a year rather than twelve, and the annual figure lands about eight percent above what the monthly label suggests. That is disclosed rather than hidden — it is in the same sentence as the price — but it is written in a way most readers will read straight past.

The billing unit is four weeks, not a calendar month, so the charge lands thirteen times a year and the annual cost runs about 8% above the monthly label.

• No compounding pharmacy is named, so you cannot check who fills the vial before you order.
• The "lose 10% or money back" guarantee is claimable only in a 14-day window after week 16.

Prime Health is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• What a flat price costs at a low dose
• The true annual cost of a plan